Global Endoprosthesis Market Size By Type (Stent Endoprosthesis, Biliary Endoprosthesis), By Application (Hospitals and Clinics, Others), By Region, And Segment Forecasts, 2023 to 2032

The Global Endoprosthesis Market was valued at USD 15.7 billion in 2023 and is projected to surpass USD 27.6 billion by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market is experiencing steady growth due to the increasing incidence of orthopedic disorders, the rise in aging populations, and growing demand for minimally invasive surgeries. Endoprostheses, commonly used for joint replacements and vascular implants, play a pivotal role in improving the quality of life for patients with chronic conditions or traumatic injuries.

Drivers:

1. Aging Global Population:

The increasing elderly population worldwide is a significant driver, as this demographic is more susceptible to joint degeneration, osteoporosis, and cardiovascular diseases that require endoprosthetic solutions.

2. Rise in Orthopedic and Cardiovascular Conditions:

A growing prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and peripheral artery disease is pushing demand for knee, hip, and vascular prostheses.

3. Technological Innovations in Implant Materials and Designs:

Advancements in biocompatible materials, 3D printing, and customizable implants have improved implant longevity and performance, thereby enhancing patient outcomes and market penetration.

Restraints:

1. High Cost of Procedures and Devices:

The high costs associated with surgical implantation and the devices themselves may limit access, especially in low-income regions.

2. Post-Surgical Complications and Implant Failures:

Risks related to infections, implant loosening, or mechanical failure can hinder patient adoption and influence healthcare provider choices.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Countries in Asia-Pacific, Latin America, and the Middle East & Africa are witnessing increased healthcare investments and access, creating strong opportunities for market players.

2. Rise in Robotic-Assisted and Minimally Invasive Surgeries:

Technologies enabling precision in endoprosthetic implantation are increasing adoption rates and patient satisfaction.

3. Customization and 3D Printing of Implants:

Tailored implants using patient-specific anatomical data offer better outcomes, creating growth potential in niche medical applications.

Market by System Type Insights:

Based on system type, Orthopedic Endoprostheses held the largest market share in 2023, driven by high volumes of hip and knee replacements. The segment benefits from well-established surgical practices, patient familiarity, and growing demand for mobility restoration in elderly populations. However, the Vascular Endoprosthesis segment is expected to witness the fastest growth, fueled by increasing incidence of cardiovascular diseases and advancements in minimally invasive endovascular repair techniques.

Market by End-use Insights:

The Hospitals segment dominated the global market in 2023, accounting for the largest share due to the availability of advanced surgical infrastructure and skilled professionals. The Ambulatory Surgical Centers (ASCs) segment is projected to grow at a higher CAGR due to lower costs, shorter recovery times, and increased focus on outpatient procedures.

Market by Regional Insights:

North America led the market in 2023 due to a high prevalence of joint-related conditions, robust healthcare infrastructure, and early adoption of advanced medical technologies. Meanwhile, Asia-Pacific is forecasted to witness the highest growth rate during the forecast period, owing to rapidly aging populations, improving access to healthcare services, and increasing surgical volumes in countries such as China and India.

Competitive Scenario:

Key players in the global endoprosthesis market include Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Stryker Corporation, Medtronic plc, Smith & Nephew plc, B. Braun Melsungen AG, MicroPort Scientific Corporation, LimaCorporate S.p.A., Exactech, Inc., and Cook Medical. These companies are actively investing in R&D, expanding their product portfolios, and entering strategic collaborations to maintain their competitive edge.

Scope of Work – Global Endoprosthesis Market

Report Metric Details

Market Size (2023) USD 15.7 billion

Projected Market Size (2031) USD 27.6 billion

CAGR (2023–2031) 7.4%

Market Segments By System Type (Orthopedic, Vascular), By End-use (Hospitals, ASCs)

Growth Drivers Aging population, Rise in orthopedic and cardiovascular conditions

Opportunities Emerging markets, 3D-printed implants, Minimally invasive procedures

Key Market Developments:

2023: Zimmer Biomet launched a new AI-powered hip replacement system to improve surgical accuracy and patient-specific outcomes.

2024: Medtronic introduced its latest-generation endovascular stent graft system designed for complex aortic aneurysm repairs.

2025: Stryker Corporation announced the acquisition of a medical robotics company to enhance its minimally invasive surgical capabilities for joint replacements.

FAQs:

1. What is the current market size of the Global Endoprosthesis Market?

The market size in 2023 is USD 15.7 billion.

2. What is the major growth driver of the Global Endoprosthesis Market?

The increasing aging population and rise in orthopedic and cardiovascular conditions are the major growth drivers.

3. Which is the largest region during the forecast period in the Global Endoprosthesis Market?

North America is the largest region due to advanced healthcare infrastructure and high adoption rates.

4. Which segment accounted for the largest market share in Global Endoprosthesis Market?

The Orthopedic Endoprostheses segment held the largest share in 2023.

5. Who are the key market players in the Global Endoprosthesis Market?

Zimmer Biomet, Johnson & Johnson, Stryker, Medtronic, and Smith & Nephew are among the leading players.